Skip to main content
. 2021 Jul 22;10(7):55. doi: 10.1038/s41389-021-00343-w

Fig. 2. Upregulation of GLT8D2 confers CDDP resistance in ovarian cancer in vitro.

Fig. 2

a Western blotting analysis of the protein expression levels of GLT8D2 in the indicated cells. GADPH was used as a loading control. b Cell viability in the indicated cells. c Quantification of the number of colonies formed by the indicated ovarian cancer cells. * P < 0.05. d Annexin V-FITC and PI staining of the indicated cells treated with cisplatin (10 μM) for 24 h. Each bar represents the mean ± SD of three independent experiments.